Scientists from eight European research institutions and companies have joined forces in the EU network "BestTreat" to develop new diagnostic and treatment options for non-alcoholic fatty liver disease. To this end, they want to make use of microorganisms that ensure functioning digestion and development of the immune system in healthy people. This so-called intestinal microbiome is disturbed in fatty liver disease, but the exact role of the microorganisms in the onset and progression of the disease is still unclear. The partners want to find out how the intestinal microbiome changes in fatty liver disease and develop methods to restore it.
Headed by Gianni Panagiotou from the Leibniz Institute for Natural Product Research and Infection Biology (Leibniz-HKI) in Jena, eight European scientists have joined forces to improve the diagnosis and therapy of non-alcoholic fatty liver disease. As part of the Innovative Training Network BestTreat, which is funded by the European Commission, they intend to train 15 doctoral researchers from September on.
Partners from Finland, Denmark, the Netherlands and Germany work together in the network and combine their scientific expertise in systems biology, human biology and microbiology to tackle this complex topic. The common goal is to identify specific patterns in the composition of the intestinal microbiome that can be used to diagnose and predict the course of the disease.
In addition, therapeutic approaches will be developed to restore the balance of the intestinal microbiome. For example, certain microorganisms will be used as so-called biotherapeutics. The young scientists receive interdisciplinary training and spend time visiting the partners during the course of their doctoral thesis. The involvement of companies allows to close the gap between academic research on the cause of the disease and the development of new diagnostic and therapeutic methods in industry.
"The cooperation of partners from different disciplines and the participation of companies opens up completely new possibilities: Not only can we elucidate the role of the intestinal microbiome in the development of non-alcoholic fatty liver disease, but we also want to develop tools to use the microbiome as a diagnostic and therapeutic tool," BestTreat coordinator Gianni Panagiotou describes the novel approach.
At the Leibniz-HKI, three of the doctoral researchers in the EU network will work on specific aspects of the extensive research program. "One research focus in Jena is the role of complex microbial communities in the development of diseases. We are very pleased to be able to gain valuable insights with BestTreat using the concrete example of intestinal microbiomes in fatty liver disease," says Axel Brakhage, Director of the Leibniz-HKI and Chair at the Friedrich Schiller University Jena, welcoming the establishment of the new network.
An underestimated disease
Non-alcoholic fatty liver disease is one of the most common diseases worldwide – it is estimated that up to 27% of the population suffer from it. The symptoms are manifold and range from fatty degeneration to cirrhosis of the liver or even liver cancer. The disease often remains undetected until severe or life-threatening complications occur. Triggers can be, for example, the diet, an imbalance in the intestinal microbiome or genetic factors. However, the underlying mechanisms are still unclear and there is no way of predicting the individual course of the disease.
Dr. Michael Ramm | idw - Informationsdienst Wissenschaft
DNA is held together by hydrophobic forces
23.09.2019 | Chalmers University of Technology
New method for the measurement of nano-structured light fields
23.09.2019 | Westfälische Wilhelms-Universität Münster
How long the battery of your phone or computer lasts depends on how many lithium ions can be stored in the battery's negative electrode material. If the battery runs out of these ions, it can't generate an electrical current to run a device and ultimately fails.
Materials with a higher lithium ion storage capacity are either too heavy or the wrong shape to replace graphite, the electrode material currently used in...
To process information, photons must interact. However, these tiny packets of light want nothing to do with each other, each passing by without altering the...
Researchers from the Department of Atomically Resolved Dynamics of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg, the University of Hamburg and the European Molecular Biology Laboratory (EMBL) outstation in the city have developed a new method to watch biomolecules at work. This method dramatically simplifies starting enzymatic reactions by mixing a cocktail of small amounts of liquids with protein crystals. Determination of the protein structures at different times after mixing can be assembled into a time-lapse sequence that shows the molecular foundations of biology.
The functions of biomolecules are determined by their motions and structural changes. Yet it is a formidable challenge to understand these dynamic motions.
At the International Symposium on Automotive Lighting 2019 (ISAL) in Darmstadt from September 23 to 25, 2019, the Fraunhofer Institute for Organic Electronics, Electron Beam and Plasma Technology FEP, a provider of research and development services in the field of organic electronics, will present OLED light strips of any length with additional functionalities for the first time at booth no. 37.
Almost everyone is familiar with light strips for interior design. LED strips are available by the metre in DIY stores around the corner and are just as often...
Later during this century, around 2060, a paradigm shift in global energy consumption is expected: we will spend more energy for cooling than for heating....
19.09.2019 | Event News
10.09.2019 | Event News
04.09.2019 | Event News
23.09.2019 | Life Sciences
23.09.2019 | Life Sciences
23.09.2019 | Materials Sciences